Back to news 04/25/2025 Press releases Marengo to Share Updated Clinical Results from STARt-001 Phase 1/2 Clinical Trial Featuring Invikafusp Alfa Monotherapy Activity in PD1 Resistant Tumors at UpcomingAACR 2025 Clinical Plenary Oral Presentation